Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis

Paul Theisen
Patient Acquisition

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach